Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms|Breast Neoplasms|Breast Cancer
Interventions: DRUG: AZD8931|DRUG: Paclitaxel|DRUG: Placebo
Sponsor: AstraZeneca